Mechanistically, ADAR1 depletion or mutation resulted in impaired A-to-I editing of dsRNA, leading to the activation of MDA5 and PKR receptors, which respectively promote immune infiltration and inhibit tumor growth. This evidence concerns the gene ADAR and neoplasm.